Sotera Health Co (NASDAQ:SHC)’s traded shares stood at 1.7 million during the last session, with the company’s beta value hitting 2.14. At the close of trading, the stock’s price was $11.87, to imply an increase of 2.95% or $0.34 in intraday trading. The SHC share’s 52-week high remains $19.40, putting it -63.44% down since that peak but still an impressive 9.52% since price per share fell to its 52-week low of $10.74. The company has a valuation of $3.36B, with an average of 3.11 million shares in intraday trading volume over the past 10 days and average of 1.68 million shares over the past 3 months.
Sotera Health Co (NASDAQ:SHC) trade information
After registering a 2.95% upside in the last session, Sotera Health Co (SHC) has traded red over the past five days. The stock hit a weekly high of 12.41, jumping 2.95% in its intraday price action. The 5-day price performance for the stock is 0.76%, and -31.55% over 30 days. With these gigs, the year-to-date price performance is -29.55%. Short interest in Sotera Health Co (NASDAQ:SHC) saw shorts transact 12.03 million shares and set a 7.94 days time to cover.
Sotera Health Co (SHC) estimates and forecasts
Looking at statistics comparing Sotera Health Co share performance against respective industry, we note that the company has underperformed competitors. Sotera Health Co (SHC) shares are -22.21% down over the last 6 months, with its year-to-date growth rate lower than industry average at -11.11% against 12.50%. The rating firms project that company’s revenue will grow 4.80% compared to the previous financial year.
Revenue forecast for the current quarter as set by 6 analysts is $244.56 million. Meanwhile, for the quarter ending Jun 2024, a total of 6 analyst(s) estimate revenue growth to $276.65 million.Earnings reports from the last fiscal year show that sales brought in $220.59 million and $255.28 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 10.90% before jumping 8.40% in the following quarter.
SHC Dividends
Sotera Health Co has its next earnings report out between May 01 and May 06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Sotera Health Co has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Sotera Health Co (NASDAQ:SHC)’s Major holders
Sotera Health Co insiders hold 3.12% of total outstanding shares, with institutional holders owning 81.26% of the shares at 83.88% float percentage. In total, 81.26% institutions holds shares in the company, led by Warburg Pincus LLC. As of Jun 29, 2023, the company held over 105.42 million shares (or 37.30% of shares), all amounting to roughly $1.99 billion.
The next major institution holding the largest number of shares is GTCR, LLC with 70.28 million shares, or about 24.87% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $1.32 billion.
We also have Janus Henderson Contrarian Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Sotera Health Co (SHC) shares. Going by data provided on Jun 29, 2023, Janus Henderson Contrarian Fund holds roughly 5.22 million shares. This is just over 1.85% of the total shares, with a market valuation of $98.39 million. Data from the same date shows that the other fund manager holds a little less at 3.1 million, or 1.10% of the shares, all valued at about 58.4 million.
